- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · May 5, 2026 | 462.35M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 463.8M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 463.5M sh |
| Shares Diluted restated | Q3 2026 · Mar 31, 2025 | 289.1M sh |
| Shares Diluted restated | Q3 2026 · Mar 31, 2025 | 289M sh |
| Stock Repurchased | Q3 2026 · Mar 31, 2026 | $1M |
| Stock Repurchased | Q3 2026 · Mar 31, 2025 | $0 |
| Dividends Paid | Q3 2026 · Mar 31, 2026 | $894M |
| Dividends Paid | Q3 2026 · Mar 31, 2025 | $550M |
| Operating Cash Flow | Q3 2026 · Mar 31, 2026 | $556M |
| Operating Cash Flow | Q3 2026 · Mar 31, 2025 | $276M |
| Short Term Debt | Q3 2026 · Mar 31, 2026 | $92M |
| Short Term Debt | Q3 2026 · Jun 30, 2025 | $116M |
| Cash And Equivalents | Q3 2026 · Mar 31, 2026 | $1.59B |
| Cash And Equivalents | Q3 2026 · Jun 30, 2025 | $827M |
| Stockholders Equity | Q3 2026 · Mar 31, 2026 | $11.65B |
| Stockholders Equity | Q3 2026 · Jun 30, 2025 | $11.73B |
| Current Liabilities | Q3 2026 · Mar 31, 2026 | $6.81B |
| Current Liabilities | Q3 2026 · Jun 30, 2025 | $6.99B |
| Total Liabilities | Q3 2026 · Mar 31, 2026 | $25.92B |
| Total Liabilities | Q3 2026 · Jun 30, 2025 | $25.33B |
| Current Assets | Q3 2026 · Mar 31, 2026 | $9.83B |
| Current Assets | Q3 2026 · Jun 30, 2025 | $8.43B |
| Total Assets | Q3 2026 · Mar 31, 2026 | $37.58B |
| Total Assets | Q3 2026 · Jun 30, 2025 | $37.07B |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | $0.60 |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | $1.55 |
| Eps Diluted restated | Q3 2026 · Mar 31, 2025 | $0.68 |
| Eps Diluted restated | Q3 2026 · Mar 31, 2025 | $1.90 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | $0.60 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | $1.55 |
| Eps Basic restated | Q3 2026 · Mar 31, 2025 | $0.68 |
| Eps Basic restated | Q3 2026 · Mar 31, 2025 | $1.91 |
| Sga Expense | Q3 2026 · Mar 31, 2026 | $488M |
| Sga Expense | Q3 2026 · Mar 31, 2026 | $1.36B |
| Sga Expense restated | Q3 2026 · Mar 31, 2025 | $266M |
| Sga Expense restated | Q3 2026 · Mar 31, 2025 | $797M |
| Rd Expense | Q3 2026 · Mar 31, 2026 | $44M |
| Rd Expense | Q3 2026 · Mar 31, 2026 | $128M |
| Rd Expense | Q3 2026 · Mar 31, 2025 | $27M |
| Rd Expense | Q3 2026 · Mar 31, 2025 | $82M |
| Net Income | Q3 2026 · Mar 31, 2026 | $278M |
| Net Income | Q3 2026 · Mar 31, 2026 | $717M |
| Net Income | Q3 2026 · Mar 31, 2025 | $196M |
| Net Income | Q3 2026 · Mar 31, 2025 | $550M |
| Operating Income | Q3 2026 · Mar 31, 2026 | $461M |
| Operating Income | Q3 2026 · Mar 31, 2026 | $1.25B |
| Operating Income | Q3 2026 · Mar 31, 2025 | $313M |
| Operating Income | Q3 2026 · Mar 31, 2025 | $922M |
| Gross Profit | Q3 2026 · Mar 31, 2026 | $1.19B |
| Gross Profit | Q3 2026 · Mar 31, 2026 | $3.35B |
| Gross Profit | Q3 2026 · Mar 31, 2025 | $654M |
| Gross Profit | Q3 2026 · Mar 31, 2025 | $1.94B |
| Cost Of Revenue | Q3 2026 · Mar 31, 2026 | $4.72B |
| Cost Of Revenue | Q3 2026 · Mar 31, 2026 | $13.76B |
| Cost Of Revenue | Q3 2026 · Mar 31, 2025 | $2.68B |
| Cost Of Revenue | Q3 2026 · Mar 31, 2025 | $7.99B |
| Revenue | Q3 2026 · Mar 31, 2026 | $5.91B |
| Revenue | Q3 2026 · Mar 31, 2026 | $17.11B |
| Revenue | Q3 2026 · Mar 31, 2025 | $3.33B |
| Revenue | Q3 2026 · Mar 31, 2025 | $9.93B |